GleamWall
中文EN

NEO NEOGENOMICS INC

Services-Testing Laboratories · Nasdaq · SEC CIK 1077183 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.1%
TTM net income YoY71.5%
TTM EPS YoY71.6%
Revenue 3-yr CAGR11.1%
Net income 3-yr CAGR—

Margins

Gross margin44.8%
Operating margin-6.3%
Net margin-4.1%
FCF margin-3.6%
EBITDA margin-1.9%

Returns

ROE-3.9%
ROA-2.3%
ROIC (approx.)-4.6%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets41.9%
Debt / equity0.47x
Current ratio3.53x
Interest coverage-15.21x

Cash quality & payout

Operating cash flow / net income-0.13x
Accruals ratio-2.7%
Payout ratio—
Capex / revenue4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$727.33M$660.57M
Cost of revenue$413.04M$370.47M
Gross profit$314.29M$290.10M
R&D expense$37.08M$31.16M
SG&A expense$273.34M$259.74M
Operating income-$115.88M-$92.11M
Interest expense$3.75M$6.62M
Pretax income-$110.27M-$80.67M
Income tax-$2.24M-$1.95M
Net income-$108.03M-$78.73M
EBITDA-$79.81M-$53.01M
EPS (diluted)——
Weighted avg. shares (diluted)128.10M126.66M
Balance sheet
Cash & equivalents$159.62M$367.01M
Receivables$159.24M$150.54M
Inventory$28.57M$26.75M
Current assets$376.29M$596.02M
PP&E, net$84.83M$94.10M
Goodwill$524.34M$522.77M
Intangibles$286.53M$339.68M
Total assets$1.36B$1.64B
Current liabilities$88.30M$301.24M
Short-term debt$0$200.78M
Long-term debt$341.86M$340.33M
Total debt$341.86M$541.11M
Total liabilities$523.27M$735.70M
Shareholders' equity$836.56M$902.34M
Net debt$182.24M$174.10M
Shares outstanding128.99M128.15M
Cash flow statement
Operating cash flow$5.23M$7.02M
Capital expenditure$27.01M$41.06M
Free cash flow-$21.78M-$34.04M
Investing cash flow-$12.34M$12.86M
Financing cash flow-$200.29M$4.65M
Depreciation & amortization$36.07M$39.10M
Stock-based compensation$41.32M$33.41M

Free plan shows the latest 2 periods; Pro shows all 16 🔒

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.